CYP2C19 and Pediatric Adverse Events During Citalopram, Escitalopram and Sertraline Treatment

CYP2C19 and Pediatric Adverse Events During Citalopram, Escitalopram and Sertraline Treatment

Original title: CYP2C19 and Pediatric Adverse Events During Citalopram, Escitalopram and Sertraline Treatment
Production: American Academy of Pediatrics
Country: United States
Year: 2020
Duration: 4
Genre: Medical documentary
Color: Color
Original language: English
Languages available: English

Synopsis:

This retrospective cohort study demonstrates that extrapolation of adult pharmacogenetic guidelines for sertraline, escitalopram, and citalopram and CYP2C19 is not appropriate for pediatric patients.